United StatesScientists have identified how a common gut bacterium, Bacteroides fragilis, contributes to the development of colorectal cancer. The research, published in Nature, reveals that a toxin produced by the bacterium called BFT attaches to a protein on colon cells called claudin-4, triggering inflammation and increasing cancer risk. This mechanism explains how the toxin damages the gut lining and initiates processes linked to tumor growth. Previous studies showed that BFT harms E-cadherin, a protein essential for the colon’s protective barrier, but the initial attachment process was unclear until now. Researchers used CRISPR technology to discover claudin-4 as the key receptor, and they developed a molecular 'decoy' that prevents the toxin from binding to cells, offering a potential therapeutic strategy.
Bias read (Center): The article discusses scientific research on gut bacteria and cancer mechanisms, focusing on biological processes and medical implications. There is no political framing, controversy, or ideological emphasis present in the content.
